Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: A cross-sectional survey study-Reference-Cited by-同舟云学术

Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: A cross-sectional survey study

Published:2020-06 Issue: Volume:36 Page:57-64
ISSN:0941-9500
Container-title:Neurology, Psychiatry and Brain Research
language:en
Short-container-title:Neurology, Psychiatry and Brain Research

Author:

Jacobsen Paula L.,Thorley Eileen M.,Curran Christopher

Funder

Takeda Pharmaceuticals U.S.A.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Neurology,General Neuroscience

Reference41 articles.

1. Sexual problems in healthy and depressed persons;Angst;International Clinical Psychopharmacology,1998

2. Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey;Ashton;Current Therapeutic Research, Clinical and Experimental,2005

3. Sexual dysfunction associated with antidepressant drugs;Baldwin;Expert Opinion on Drug Safety,2004

4. Antidepressant drugs and sexual dysfunction;Baldwin;The British Journal of Psychiatry,2013

5. Impact of antidepressant drugs on sexual function and satisfaction;Baldwin;CNS Drugs,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressant use and treatment-emergent sexual dysfunction among patients with major depressive disorder: Results from an internet-based survey study;Journal of Affective Disorders Reports;2024-04

2. Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL study;Neuropsychopharmacology;2023-10-24

3. Digital health technologies and major depressive disorder;CNS Spectrums;2023-04-12

4. SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC?;Current Topics in Behavioral Neurosciences;2023

5. Designing clinically useful psychopharmacological trials: challenges and ways forward;The Lancet Psychiatry;2022-07